Heart Failure Pledge campaign launches in run-up to European Parliament elections

News & Events

23 April 2019

HFPN has co-created a new campaign calling on MEPs and European Parliamentary candidates to pledge their support for improving the lives of EU citizens with heart failure.

The Heart Failure Pledge campaign is led by the Heart Failure Patient Council of the Global Heart Hub, a non-profit organisation. HFPN is supporting the campaign and has developed a dedicated website to house the pledge.

Heart failure is a serious and complex chronic syndrome, which affects at least 15 million people in Europe. It leads to poor quality of life and survival for many people – worse than for most common types of cancer. It also accounts for significant healthcare expenditure, and this is set to grow; hospital admissions due to heart failure are projected to rise by 50% over the next 25 years. Heart failure poses a sustainability challenge for our healthcare systems and societies, and requires urgent action.

The Heart Failure Pledge campaign was launched on 23 April 2019 and will finish after the European Parliament elections on 23–26 May 2019.


The Global Heart Hub (previously known as the International Heart Hub) is the first global non-profit organisation that brings together and supports the creation of patient groups from every country in the world to raise awareness of heart disease and improve lives.

The Heart Failure Policy Network is an independent, multidisciplinary group of healthcare professionals, patient advocacy groups, policymakers and other stakeholders from across Europe whose goal is to raise awareness of the unmet needs surrounding heart failure and its care.

For more information on the Heart Failure Pledge campaign, please visit: www.hfpledge.eu


More from News & Events

Strategic consensus on heart failure in Portugal launched
Strategic consensus on heart failure in Portugal launched...
06 October 2020
The HFPN has collaborated with the Institute of Health Sciences of the Catholic University of Portugal to develop a strategic consensus on heart failure in Portugal....
Read article
HFPN presents Portuguese work at Portuguese Society of Cardi
HFPN presents Portuguese work at Portuguese Society of Cardi...
24 January 2020
The HFPN presented recent work at the Annual Meeting of the Heart Failure Study Group of the Portuguese Society of Cardiology....
Read article
The Heart Failure Policy Network is made possible with financial support from Novartis Pharma, AstraZeneca and Vifor Pharma. The content produced by the Network is non-promotional and not biased to any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members.